Defocus Media

Dr. Danielle Richardson shares a powerful reminder for every optometrist, entrepreneur, and healthcare professional: authenticity is your greatest advantage.

Rather than focusing on competitors, she focuses on serving her patients, creating a unique experience, and building a practice that reflects her values. Success comes from owning your lane, understanding your audience, and delivering care in a way only you can.

Indication
Xiidra® (lifitegrast ophthalmic solution) 5% is indicated for the treatment of signs and symptoms of dry eye disease (DED).

Important Safety Information
Xiidra is contraindicated in patients with known hypersensitivity to lifitegrast or to any of the other ingredients.

Wondering why Xiidra is a trusted choice that stands out in treating dry eye inflammation? Unlike cyclosporine, Xiidra provides a 3-in-1 defense against dry eye inflammation, to help break the dry eye inflammatory cycle.1-5*

*The exact mechanism of action of Xiidra in dry eye disease is unknown.

And the clinical data shows that Xiidra provides early relief and long-term control of dry eye symptoms.1†

†Xiidra significantly reduced symptoms of eye dryness at 2 weeks (based on Eye Dryness Score compared to vehicle) in 2 of 4 studies, with improvements observed at 6 and 12 weeks in all 4 studies.

Want to elevate patient care with rapid results? Tune in to learn more and explore experts insights.

INDICATION
Xiidra® (lifitegrast ophthalmic solution) 5% is indicated for the treatment of signs and symptoms of dry eye disease (DED).

IMPORTANT SAFETY INFORMATION
• Xiidra is contraindicated in patients with known hypersensitivity to lifitegrast or to any of the other ingredients.
• In clinical trials, the most common adverse reactions reported in 5-25% of patients were instillation site irritation, dysgeusia and reduced visual acuity. Other adverse reactions reported in 1% to 5% of the patients were blurred vision, conjunctival hyperemia, eye irritation, headache, increased lacrimation, eye discharge, eye discomfort, eye pruritus and sinusitis.
• To avoid the potential for eye injury or contamination of the solution, patients should not touch the tip of the single-use container to their eye or to any surface.
• Contact lenses should be removed prior to the administration of Xiidra and may be reinserted 15 minutes following administration.
• Safety and efficacy in pediatric patients below the age of 17 years have not been established.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

The exact mechanisms of action of Xiidra and cyclosporine in dry eye disease are not known.

*There are no head-to-head studies of Xiidra and cyclosporine.

†Xiidra significantly reduced symptoms of eye dryness at 2 weeks (based on Eye Dryness Score compared to vehicle) in 2 of 4 studies, with improvements observed at 6 and 12 weeks in all 4 studies.

References: 1. Xiidra. Prescribing information. Bausch & Lomb Inc. 2. Restasis. Prescribing information. Allergan; 2017. 3. Vevye. Prescribing information. Harrow Eye, LLC; 2023. 4. Cequa. Prescribing information. Sun Pharmaceutical Industries Limited; 2022. 5. Donnenfeld ED, Perry HD, Nattis AS, Rosenberg ED. Lifitegrast for the treatment of dry eye disease in adults. Expert Opin Pharmacother. 2017;18(14):1517-1524. doi:10.1080/14656566.2017.1372748

Please see full Prescribing Information for Xiidra at XIIDRA-ECP.COM.

©2026 Bausch & Lomb Inc. XDR.0027.USA.26

Marketing isn’t just about getting patients through the door, it’s about preparing them before they ever sit in the exam chair.

In this episode of 4 the Record, Dr. Wes McCann explains why the most successful optometry practices use marketing as a patient education tool, not just a lead generation strategy. From social media and email campaigns to website content and branding, every touchpoint helps build trust, increase awareness of specialty services, and create more meaningful patient conversations.

In this thought-provoking conversation, Dr. Meenal Agarwal explores how excessive screen time may influence the brain’s spatial awareness and sense of safety, potentially contributing to changes in social behavior, confidence, and even anxiety in today’s children.

From teens avoiding driving to kids shying away from team sports, this discussion challenges us to think beyond screen time limits and consider how vision and brain development are connected.

Artificial intelligence is changing eye care faster than ever before.

Join Dr. Darryl Glover and Dr. Osama Said LIVE tomorrow at 6:00 PM EDT for a powerful conversation on AI, clinical oculomics, predictive healthcare, and the future of optometry.

Discover how eye care professionals can leverage innovation, data, and technology to improve patient outcomes, elevate patient experience, and help shape the next era of healthcare.

Topics include:
• AI in optometry
• Clinical oculomics
• Predictive healthcare
• Innovation in eye care
• The future of optometry

Streaming live on Defocus Media — the #1 eye care podcast network.

Dr. Osama Said shared a mind-blowing insight on the future of AI in healthcare.
Researchers uploaded 280,000 retinal photos into an AI model with zero patient history, demographics, or context.

The result? AI was able to predict cardiovascular disease risk with nearly 90% accuracy — while also identifying age, smoking status, blood pressure, and even gender from retinal scans alone.

The future of healthcare may start inside the eye exam room.

Join Dr. Darryl Glover and The Eye Care Coach, Dean Thompson, for a powerful conversation on patient experience in eye care, doctor-optical handoffs, optical staff training, communication, remakes, and the hidden profit bleeds impacting practices every day.

Learn practical strategies to improve patient retention, strengthen team communication, elevate doctor-patient interactions, and create a more seamless patient journey from check-in to eyewear delivery.

If you’re an optometrist, optician, practice owner, or eye care professional looking to strengthen your practice culture and improve the patient experience, this is a conversation you do not want to miss.

One of the most interesting parts of this dry eye conversation?

The discussion around the TOP 3 emerging trends shaping the future of patient care. 👁️

The first trend mentioned:

🧬 Biologics.

There’s growing excitement around biologic therapies and regenerative approaches within ocular surface disease management.

The conversation highlighted how biologics may continue becoming a much bigger part of dry eye care moving forward — especially as clinicians look for more advanced ways to support healing and improve outcomes.

The second trend?

⚡ Peptides and regenerative-focused innovation.

More attention is being placed on therapies designed to support the ocular surface at a deeper level instead of simply masking symptoms temporarily.

That shift toward restoration and long-term management is changing the conversation around dry eye completely.

And the third major trend discussed:

💆 Dynamic muscle stimulation technology, including TriLift.

The idea that facial muscle stimulation and advanced aesthetic-based technologies may also play a role in dry eye management is something many clinicians are beginning to pay closer attention to.

What stood out most from the discussion was this:

Dry eye care is no longer just about artificial tears.

The future appears to be moving toward more personalized, regenerative, and technology-driven approaches focused on long-term ocular surface health.

Patients are becoming more educated.
Technology is evolving rapidly.
And treatment strategies are expanding faster than ever before. 📈

The clinicians who stay curious and continue learning may be the ones best positioned to lead the next era of dry eye care.

Which of these emerging trends do you think has the MOST potential over the next 5 years?

Conversations around financial wellness in optometry are becoming increasingly important across the profession. On a recent episode of the Depth Perception Podcast, Dr. Jasdeep Singh, Dr. Svetlana Nunez, and Dr. Chris Lopez discussed the challenges tied to income, student loan debt, burnout, and building long-term financial stability within eye care.